Effectiveness of varicella vaccine in children infected with HIV

Journal of Infectious Diseases

Volumn 201, Issue 12, 2010, Pages 1806-1810

  Son, Moeun ^a   Shapiro, Eugene D ^b   Larussa, Philip ^a   Neu, Natalie ^a   Michalik, David E ^a   Meglin, Michelle ^c   Jurgrau, Andrea ^a   Bitar, Wally ^c   Vasquez, Marietta ^b   Flynn, Patricia ^c   Gershon, Anne A ^a  

^a College of Physicians and Surgeons ^*  (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CHICKENPOX; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; COHORT ANALYSIS; DRUG EFFICACY; FEMALE; HERPES ZOSTER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; INCIDENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MEDICAL RESEARCH; PATIENT MONITORING; PERINATAL INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; UNIVERSITY; VACCINATION; IMMUNOLOGY;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; FEMALE; HERPES ZOSTER; HIV INFECTIONS; HUMANS; MALE;

EID: 77952580664     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/652798     Document Type: Article

References (15)

1. Gershon A, Mervish N, LaRussa P, et al. Varicella-zoster virus infection in children with underlying HIV infection. J Infect Dis 1997; 176:1496-1500.
2. Gershon A, Takahashi M, Seward J. Live attenuated varicella vaccine. In: Plotkin S, Orenstein W, Offit P, eds. Vaccines. 5th ed. Philadelphia, PA: WB Saunders, 2008:915-958.
3. Centers for Disease Control and Prevention. Prevention of varicella: update. MMWR Recomm Rep 1999; 48(RR-6):1-6.
4. Centers for Disease Control and Prevention. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007; 56(RR-4):1-40.
5. 5. Levin MJ, Gershon AA, Weinberg A, et al. Immunization of HIVinfected children with varicella vaccine. J Pediatr 2001; 139:305-310. (Pubitemid 32721722)
6. 6. Levin MJ, Gershon AA, Weinberg A, Song LY, Fentin T, Nowak B. Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4+ T cells. J Infect Dis 2006; 194:247-255. (Pubitemid 44087197)
7. Abrahamson JH, Ghalinger PM. Computer programs for epidemiologists: PEPI version 4. Salt Lake City, UT: Sagebrush Press, 2001:179-186.
8. 8. Galea SA, Sweet A, Beninger P, et al. The safety profile of varicella vaccine: a 10-year review. J Infect Dis 2008; 197(suppl 2):S165-S169. (Pubitemid 351590166)
9. 9. Gershon AA, Chen J, Gershon MD. A model of lytic, latent, and reactivating varicella-zoster virus infections in isolated enteric neurons. J Infect Dis 2008; 197(suppl 2):S61-S65. (Pubitemid 351590148)
10. 10. Chen JJ, Zhu Z, Gershon AA, Gershon MD. Mannose 6-phosphate receptor dependence of varicella zoster virus infection in vitro and in the epidermis during varicella and zoster. Cell 2004; 119:915-926. (Pubitemid 40037606)
11. 11. Puthanakit T, Oberdorfer P, Akarathum N, Wannarit P, Sirisanthana T, Sirisanthana V. Immune reconstitution syndrome after highly active antiretroviral therapy in human immunodeficiency virus-infected thai children. Pediatr Infect Dis J 2006; 25:53-58. (Pubitemid 43361477)
12. 12. Tangsinmankong N, Kamchaisatian W, Lujan-Zilbermann J, Brown CL, Sleasman JW, Emmanuel PJ. Varicella zoster as a manifestation of immune restoration disease in HIV-infected children. J Allergy Clin Immunol 2004; 113:742-746. (Pubitemid 38530432)
13. 13. Gona P, Van Dyke RB, Williams PL, et al. Incidence of opportunistic and other infections in HIV-infected children in the HAART era. JAMA 2006; 296:292-300. (Pubitemid 44079313)
14. Levin MJ, Anderson JP, Seage GR 3rd, Williams PL. Short-term and long-term effects of highly active antiretroviral therapy on the incidence of herpes zoster in HIV-infected children. J Acquir Immune Defic Syndr 2009; 50:182-191.
15. Wood SM, Shah SS, Steenhoff AP, Rutstein RM. Primary varicella and herpes zoster among HIV-infected children from 1989 to 2006. Pediatrics 2008; 121:e150-e156.